Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 4/2022

23.02.2022 | Acute Pain Medicine (R Urman, Section Editor)

Perioperative Breast Analgesia: a Systematic Review of the Evidence for Perioperative Analgesic Medications

verfasst von: Robert B. Maniker, James Damiano, Ryan M. J. Ivie, Martin Pavelic, Glenn E. Woodworth

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Breast surgery is common and may result in significant acute as well as chronic pain. A wide range of pharmacologic interventions is available including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), N-methyl-d-aspartate (NMDA) receptor antagonists, anticonvulsants, and other non-opioids with analgesic properties. We present a review of the evidence for these pharmacologic interventions. A literature search of the MEDLINE database was performed via PubMed with combined terms related to breast surgery, anesthesia, and analgesia. Articles were limited to randomized controlled trial (RCT) design, adult patients undergoing elective surgery on the breast (not including biopsy), and pharmacologic interventions only. Article titles and abstracts were screened, and risk of bias assessments were performed.

Recent Findings

The search strategy initially captured 7254 articles of which 60 articles met the full inclusion criteria. Articles were organized according to intervention: 6 opioid agonists, 14 NSAIDs and acetaminophen, 4 alpha-2 agonists, 7 NMDA receptor antagonists, 6 local anesthetics, 7 steroids, 15 anticonvulsants (one of which also discussed an NMDA antagonist), 1 antiarrhythmic, and 2 serotonin reuptake inhibitors (one of which also studied an anticonvulsant).

Summary

A wide variety of medications is effective for perioperative breast analgesia, but results vary by agent and dose. The most efficacious are likely NSAIDs and anticonvulsants. Some agents may also decrease the incidence of chronic postoperative pain, including flurbiprofen, gabapentin, venlafaxine, and memantine. While many individual agents are well studied, optimal combinations of analgesic medications remain unclear.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
3.
Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer. 2008;99(4):604–10.CrossRefPubMedPubMedCentral
4.
Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95(5):409–18.CrossRefPubMed
5.
Roth RS, Lowery JC, Davis J, Wilkins EG. Persistent pain following postmastectomy breast reconstruction: long-term effects of type and timing of surgery. Ann Plast Surg. 2007;58(4):371–6.CrossRefPubMed
6.
Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain. 2013;14(10):1185–95.CrossRefPubMed
7.
Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.CrossRefPubMed
8.
Rothemund Y, Grusser SM, Liebeskind U, Schlag PM, Flor H. Phantom phenomena in mastectomized patients and their relation to chronic and acute pre-mastectomy pain. Pain. 2004;107(1–2):140–6.CrossRefPubMed
9.
Ahmed A, Bhatnagar S, Rana SP, Ahmad SM, Joshi S, Mishra S. Prevalence of phantom breast pain and sensation among postmastectomy patients suffering from breast cancer: a prospective study. Pain Pract. 2014;14(2):E17-28.CrossRefPubMed
10.
van Elk N, Steegers MA, van der Weij LP, Evers AW, Hartman EH, Wilder-Smith OH. Chronic pain in women after breast augmentation: prevalence, predictive factors and quality of life. Eur J Pain. 2009;13(6):660–1.CrossRefPubMed
11.
Cho AR, Kwon JY, Kim KH, Lee HJ, Kim HK, Kim ES, et al. The effects of anesthetics on chronic pain after breast cancer surgery. Anesth Analg. 2013;116(3):685–93.CrossRefPubMed
12.
Bokhari FN, McMillan DE, McClement S, Daeninck PJ. Pilot study of a survey to identify the prevalence of and risk factors for chronic neuropathic pain following breast cancer surgery. Oncol Nurs Forum. 2012;39(2):E141–9.CrossRefPubMed
13.
Fassoulaki A, Melemeni A, Staikou C, Triga A, Sarantopoulos C. Acute postoperative pain predicts chronic pain and long-term analgesic requirements after breast surgery for cancer. Acta Anaesthesiol Belg. 2008;59(4):241–8.PubMed
14.
Iohom G, Abdalla H, O’Brien J, Szarvas S, Larney V, Buckley E, et al. The associations between severity of early postoperative pain, chronic postsurgical pain and plasma concentration of stable nitric oxide products after breast surgery. Anesth Analg. 2006;103(4):995–1000.CrossRefPubMed
15.
Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain. 2006;7(9):626–34.CrossRefPubMedPubMedCentral
16.
Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015.
17.
Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66(2–3):195–205.CrossRefPubMed
18.
•• Woodworth GE, Ivie R, Nelson S, Walker C and Maniker RB. Perioperative breast analgesia: a review of anatomy and regional techniques. Reg Anes Pain Med. 2017;42(5):609-631. This systematic review summarized the evidence for procedural interventions such as epidural, paravertebral, and peripheral nerve blocks to treat perioperative pain after breast surgery. Epidural and paravertebral blocks were noted to be effective. These procedures ideally complement a multimodal analgesic medication regimen.
19.
Pasternak GW. Mu opioid pharmacology: 40 years to the promised land. Adv Pharmacol. 2017;82:261–91.CrossRefPubMed
20.
21.
Sun T, Sacan O, White PF, Coleman J, Rohrich RJ, Kenkel JM. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesth Analg. 2008;106(3):950–8.CrossRefPubMed
22.
Murata-Ooiwa M, Tsukada S, Wakui M. Intravenous acetaminophen in multimodal pain management for patients undergoing total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Arthroplasty. 2017;32(10):3024–8.CrossRefPubMed
23.
Bonde C, Khorasani H, Hoejvig J, Kehlet H. Cyclooxygenase-2 inhibitors and free flap complications after autologous breast reconstruction: a retrospective cohort study. J Plast Reconstr Aesthet Surg. 2017;70(11):1543–6.CrossRefPubMed
24.
Richards C. The effect of opioids, alcohol, and nonsteroidal anti-inflammatory drugs on fracture union. Orthop Clin North Am. 2017;48:433–43.CrossRefPubMed
25.
Bosek V, Cox CE. Comparison of analgesic effect of locally and systemically administered ketorolac in mastectomy patients. Ann Surg Oncol. 1996;3(1):62–6.CrossRefPubMed
26.
Brubaker L, Kendall L, Reina E. Multimodal analgesia: a systematic review of local NSAIDs for non-ophthalmologic postoperative pain management. Int J Surg. 2016;32:158–66.CrossRefPubMed
27.
Bekker A, Haile M, Kline R, Didehvar S, Babu R, Martiniuk F, Urban M. The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. J Neurosurg Anesthesiol. 2013;25(1):16–24.CrossRefPubMedPubMedCentral
28.
Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, Skrivanek G, Macaluso A, Shah M, Provost DA. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106(6):1741–8.CrossRefPubMed
29.
Blaudszun G, Lysakowski C, Elia N, Tramèr MR. Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2012;116(6):1312–22.CrossRefPubMed
30.
Nguyen V, Tiemann D, Park E, Salehi A. Alpha-2 agonists. Anesthesiol Clin. 2017;35(2):233–45.CrossRefPubMed
31.
Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat. Brain Res. 1987;424(2):402–6.CrossRefPubMed
32.
Davar G, Hama A, Deykin A, Vos B, Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 1991;553(2):327–30.CrossRefPubMed
33.
Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370–80.CrossRefPubMedPubMedCentral
34.
Romanelli F, Smith KM. Dextromethorphan abuse: clinical effects and management. J Am Pharm Assoc. 2009;49(2):e20–5.CrossRef
35.
Kornhuber J, Weller M, Schoppmeyer K, Riederer P. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl. 1994;43:91–104.PubMed
36.
Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des. 2005;11(21):2671–86.CrossRefPubMed
37.
Pere P, Lindgren L, Vaara M. Poor antibacterial effect of ropivacaine: comparison with bupivacaine. Anesthesiology. 1999;91(3):884–6.CrossRefPubMed
38.
De Oliveira GS Jr, Fitzgerald P, Streicher LF, Marcus RJ, McCarthy RJ. Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery. Anesth Analg. 2012;115(2):262-7.
39.
Vigneault L, Turgeon AF, Côté D, Lauzier F, Zarychanski R, Moore L, McIntyre LA, Nicole PC, Fergusson DA. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011;58(1):22–37.CrossRefPubMed
40.
Xu J, Yang J, Lin P, Rosenquist E, Cheng J. Intravenous therapies for complex regional pain syndrome: a systematic review. Anesth Analg. 2016;122(3):843–56.CrossRefPubMed
41.
Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2019;2019(10).
42.
De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2011;115(3):575-88.
43.
Aasboe V, Raeder JC, Groegaard B. Betamethasone reduces postoperative pain and nausea after ambulatory surgery. Anesth Analg. 1998;87(2):319–23.CrossRefPubMed
44.
Goppelt-Struebe M, Wolter D, Resch K. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br J Pharmacol. 1989;98(4):1287–95.CrossRefPubMedPubMedCentral
45.
46.
Mahran E, Hassan ME. Comparison of pregabalin versus ketamine in postoperative pain management in breast cancer surgery. Saudi J Anaesth. 2015;9(3):253–7.CrossRefPubMedPubMedCentral
47.
Calandre EP, Rico-Villademoros F, Slim M. Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Rev Neurother. 2016;16(11):1263–77.CrossRefPubMed
48.
Taylor CP. Mechanisms of action of gabapentin. Rev Neurol (Paris). 1997;153(Suppl 1):S39-45.
49.
Fuzier R, Serres I, Guitton E, Lapeyre-Mestre M, Montastruc JL. French Network of Pharmacovigilance Centres. Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database. Drug Saf. 2013;36(1):55–62.
50.
•• Verret M, Lauzier F, Zarychanski R, Perron C, Savard X, Pinard AM, Leblanc G, Cossi MJ, Neveu X, Turgeon AF. Canadian Perioperative Anesthesia Clinical Trials (PACT) Group. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133(2):265–279. This meta-analysis pooled 281 studies of perioperative gabapentinoid use and showed minimal benefit across all surgical types, but other reviews on specific surgical interventions like breast surgery have shown larger effects of gabapentinoids on perioperative pain.
51.
Parker RB, McCollam PL. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia. Clin Pharm. 1990;9(4):261–71.PubMed
52.
Vincenzi F, Pasquini S, Borea PA, Varani K. Targeting adenosine receptors: a potential pharmacological avenue for acute and chronic pain. Int J Mol Sci. 2020;21(22):8710.CrossRefPubMedCentral
53.
Segerdahl M, Ekblom A, Sandelin K, Wickman M, Sollevi A. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg. 1995;80(6):1145–9.PubMed
54.
Doi T, Kuzuna S, Maki Y. Spinal antinociceptive effects of adenosine compounds in mice. Eur J Pharmacol. 1987;137(2–3):227–31.
55.
Vapaatalo H, Onken D, Neuvonen PJ, Westermann E. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA). Arzneimittelforschung. 1975;25(3):407–10.PubMed
56.
Jin X, Mi W. Adenosine for postoperative analgesia: a systematic review and meta-analysis. PLoS One. 2017;12(3):e0173518.
57.
Taylor C, Fricker AD, Devi LA, Gomes I. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. Cell Signal. 2005;17(5):549–57.CrossRefPubMedPubMedCentral
58.
Miller, Ronald D. Miller’s anesthesia. 7th ed. Philadelphia, PA: Churchill Livingstone/Elsevier, 2010.
59.
Humble SR, Dalton AJ, Li L. A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2015;19(4):451–65.CrossRefPubMed
60.
Castro-Alves LJ, Oliveira de Medeiros AC, Neves SP, Carneiro de Albuquerque CL, Modolo NS, De Azevedo VL, De Oliveira GS Jr. Perioperative duloxetine to improve postoperative recovery after abdominal hysterectomy: a prospective, randomized, double-blinded, placebo-controlled study. Anesth Analg. 2016;122(1):98–104.
61.
Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol. 2017;8:307.CrossRefPubMedPubMedCentral
62.
Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26(5):381–5.CrossRefPubMed
63.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.CrossRefPubMed
64.
Kampe S, Warm M, Kaufmann J, Hundegger S, Mellinghoff H, Kiencke P. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer. Curr Med Res Op. 2004;20(2):199–202.CrossRef
65.
Silvasti M, Svartling N, Pitkänen M, Rosenberg PH. Comparison of intravenous patient-controlled analgesia with tramadol versus morphine after microvascular breast reconstruction. Eur J Anaesth. 2000;17(7):448–55.CrossRef
66.
Besic N, Smrekar J, Strazisar B. Acute pain and side effects after tramadol in breast cancer patients: results of a prospective double-blind randomized study. Sci Rep. 2020;10(1):18766.CrossRefPubMedPubMedCentral
67.
Yarussi A, Sands R, Edge S, Lema MJ, de Leon-Casasola OA. Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: a randomized, double-blind, placebo-controlled study. Regional Anesth Pain Med. 1999;24(2):142–5.
68.
Shen X, Wang F, Xu S, Ma L, Liu Y, Feng S, et al. Comparison of the analgesic efficacy of preemptive and preventive tramadol after lumpectomy. Pharmacological reports: PR. 2008;60(3):415–21.PubMed
69.
Kampe S, Wolter K, Warm M, Dagtekin O, Shaheen S, Landwehr S. Clinical equivalence of controlled-release oxycodone 20 mg and controlled-release tramadol 200 mg after surgery for breast cancer. Pharmacology. 2009;84(5):276–81.CrossRefPubMed
70.
Parsa AA, Soon CWM, Parsa FD. The use of celecoxib for reduction of pain after subpectoral breast augmentation. Aesthetic Plast Surg. 2005;29(6):441–5.CrossRefPubMed
71.
•• van Helmond N, Steegers MA, Filippini-de Moor GP, Vissers KC, Wilder-Smith OH. Hyperalgesia and persistent pain after breast cancer surgery: a prospective randomized controlled trial with perioperative COX-2 inhibition. PLOS One. 2016;11(12):e0166601. An RCT finding that COX-2 inhibitors can be valuable in preventing acute postoperative pain on movement, but their role in preventing pain sensitization and persistent pain is limited.
72.
Gehling M, Arndt C, Behrendt IC, Wulf H, Eberhart LHJ. Is the prophylactic use of non-opioids for post-operative analgesia always indicated? A randomized controlled trial in breast surgery. Ambul Surg. 2011;16(4):93–8.
73.
Legeby M, Sandelin K, Wickman M, Olofsson C. Analgesic efficacy of diclofenac in combination with morphine and paracetamol after mastectomy and immediate breast reconstruction. Acta Anaesthesiol Scand. 2005;49(9):1360–6.CrossRefPubMed
74.
Sun M, Liao Q, Wen L, Yan X, Zhang F, Ouyang W. Effect of perioperative intravenous flurbiprofen axetil on chronic postmastectomy pain. Journal of Central South University Medical sciences. 2013;38(7):653–60.PubMed
75.
Ohnesorge H, Bein B, Hanss R, Francksen H, Mayer L, Scholz J, et al. Paracetamol versus metamizol in the treatment of postoperative pain after breast surgery: a randomized, controlled trial. Eur J Anaesth. 2009;26(8):648–53.CrossRef
76.
Nonaka T, Hara M, Miyamoto C, Sugita M, Yamamoto T. Comparison of the analgesic effect of intravenous acetaminophen with that of flurbiprofen axetil on post-breast surgery pain: a randomized controlled trial. J Anesth. 2016;30(3):405–9.CrossRefPubMed
77.
Kang JE, Park SK, Song IK, Lee JH, Kim JT, Kim HS. Comparison of the efficacy and safety of different doses of propacetamol for postoperative pain control after breast surgery. Pain Manag Nurs. 2015;16(3):367–71.CrossRefPubMed
78.
Priya V, Divatia JV, Sareen R, Upadhye S. Efficacy of intravenous ketoprofen for pre-emptive analgesia. J Postgrad Med. 2002;48(2):109–12.PubMed
79.
Kampe S, Warm M, Landwehr S, Dagtekin O, Haussmann S, Paul M, et al. Clinical equivalence of IV paracetamol compared to IV dipyrone for postoperative analgesia after surgery for breast cancer. Curr Med Res Opin. 2006;22(10):1949–54.CrossRefPubMed
80.
Mitchell A, McCrea P, Inglis K, Porter G. A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery. Ann Surg Oncol. 2012;19(12):3792–800.CrossRefPubMed
81.
Na HS, Oh AY, Koo BW, Lim DJ, Ryu JH, Han JW. Preventive analgesic efficacy of nefopam in acute and chronic pain after breast cancer surgery: a prospective, double-blind, and randomized trial. Medicine. 2016;95(20):e3705.
82.
• Kim SH, Oh YJ, Park BW, Sim J, Choi YS. Effects of single-dose dexmedetomidine on the quality of recovery after modified radical mastectomy: a randomised controlled trial. Minerva anesthesiologica. 2013;79(11):1248-58. This RCT demonstrated that patients who received a single dose of dexmedetomidine intraoperatively had significantly higher QoR-40 scores and significantly reduced opioid requirement postoperatively. The bolus was also effective in lowering the incidence of PONV.
83.
Das R, Das RK, Sahoo S, Nanda S. Role of dexmedetomidine as an anaesthetic adjuvant in breast cancer surgery as a day-care procedure: a randomised controlled study. Indian J Anaesth. 2018;62(3):182–7.CrossRefPubMedPubMedCentral
84.
Mohamed SA, Abdel-Ghaffar HS, Hassan NA, El Sherif FA, Shouman SA, Omran MM, Hassan SB, Allam AAAE, Sayed DG. Pharmacokinetics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer. Anesth Analg. 2021;132(2):456–64.CrossRefPubMed
85.
Oddby-Muhrbeck E, Eksborg S, Bergendahl HT, Muhrbeck O, Lönnqvist PA. Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology. 2002;96(5):1109–14.CrossRefPubMed
86.
Wong CS, Wu CT, Yu JC, Yeh CC, Lee MM, Tao PL. Preincisional dextromethorphan decreases postoperative pain and opioid requirement after modified radical mastectomy. Can J Anesth. 1999;46(12):1122–6.CrossRefPubMed
87.
Eisenberg E, Pud D, Koltun L, Loven D. Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study. J Pain. 2007;8(3):223–9.CrossRefPubMed
88.
Adam F, Libier M, Oszustowicz T, Lefebvre D, Beal J, Meynadier J. Preoperative small-dose ketamine has no preemptive analgesic effect in patients undergoing total mastectomy. Anesth Analg. 1999;89(2):444–7.CrossRefPubMed
89.
Nayak BM, Misra S, Mitra JK, Sahoo AK. Effect of preoperative subanaesthetic ketamine on postoperative pain in women undergoing modified radical mastectomy: a randomised control trial. Eur J Anaesthesiol. 2021;38(5):556–8.CrossRefPubMed
90.
Kang C, Cho AR, Kim KH, Lee EA, Lee HJ, Kwon JY, Kim H, Kim E, Baik JS, Kim C. Effects of intraoperative low-dose ketamine on persistent postsurgical pain after breast cancer surgery: a prospective, randomized, controlled, double-blind study. Pain Physician. 2020;23(1):37–47.PubMed
91.
Morel V, Joly D, Villatte C, Dubray C, Durando X, Daulhac L, Coudert C, Roux D, Pereira B, Pickering G. Memantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patients. PLoS One. 2016;11(4):e0152741.
92.
Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anes Pain Med. 2000;25(4):350–5.CrossRef
93.
Akan A, Eryavuz Y, Kamali S, Simşek S, Hot S, Bademci R. A randomized, placebo controlled study: EMLA in minor breast surgery. Minerva Chir. 2012;67(2):181–5.PubMed
94.
95.
•• Kendall MC, McCarthy RJ, Panaro S, Goodwin E, Bialek JM, Nader A, De Oliveira GS Jr. The effect of intraoperative systemic lidocaine on postoperative persistent pain using initiative on methods, measurement, and pain assessment in clinical trials criteria assessment following breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Pain Pract. 2018;18(3):350-359. Although other studies showed that intravenous lidocaine did not significantly reduce acute postoperative pain for breast surgery, this RCT demonstrated that the reported incidence of persistent pain at 6 months after breast cancer surgery was significantly lower in the group that received lidocaine bolus plus infusion during surgery.
96.
Khan JS, Hodgson N, Choi S, Reid S, Paul JE, Hong NJL, Holloway C, Busse JW, Gilron I, Buckley DN, McGillion M, Clarke H, Katz J, Mackey S, Avram R, Pohl K, Rao-Melacini P, Devereaux PJ. Perioperative pregabalin and intraoperative lidocaine infusion to reduce persistent neuropathic pain after breast cancer surgery: a multicenter, factorial, randomized, controlled pilot trial. J Pain. 2019;20(8):980–93.CrossRefPubMed
97.
Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain. 2012;28(7):567–72.CrossRefPubMed
98.
Gomez-Hernandez J, Orozco-Alatorre AL, Dominguez-Contreras M, Oceguera-Villanueva A, Gomez-Romo S, Alvarez Villasenor AS, et al. Preoperative dexamethasone reduces postoperative pain, nausea and vomiting following mastectomy for breast cancer. BMC Cancer. 2010;10(1):692.CrossRefPubMedPubMedCentral
99.
•• Cortés-Flores AO, Jiménez-Tornero J, Morgan-Villela G, Delgado-Gómez M, Zuloaga-Fernández Del Valle CJ, García-Rentería J, Rendón-Félix J, Fuentes-Orozco C, Macías-Amezcua MD, Ambriz-González G, Alvarez-Villaseñor AS, Urias-Valdez D, Chavez-Tostado M, Contreras-Hernández GI, González-Ojeda A. Effects of preoperative dexamethasone on postoperative pain, nausea, vomiting and respiratory function in women undergoing conservative breast surgery for cancer: results of a controlled clinical trial. Eur J Cancer Care (Engl). 2018;27(1). Dexamethasone 8 mg was shown to be effective in reducing postoperative pain scores and frequency of nausea/vomiting for patients undergoing partial mastectomy at 1 h, 6 h, 12 h, and 24 h postoperatively compared to placebo.
100.
Olanders KJ, Lundgren GA, Johansson AM. Betamethasone in prevention of postoperative nausea and vomiting following breast surgery. J Clin Anesth. 2014;26(6):461–5.CrossRefPubMed
101.
Hval K, Thagaard KS, Schlichting E, Raeder J. The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery. Anesth Analg. 2007;105(2):481–6.CrossRefPubMed
102.
Steinthorsdottir KJ, Awada HN, Abildstrøm H, Kroman N, Kehlet H, Aasvang EK. Dexamethasone dose and early postoperative recovery after mastectomy: a double-blind, randomized trial. Anesthesiology. 2020;132(4):678–91.CrossRefPubMed
103.
Wattwil M, Thörn SE, Lövqvist A, Wattwil L, Gupta A, Liljegren G. Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand. 2003;47(7):823–7.CrossRefPubMed
104.
Romundstad L, Breivik H, Roald H, Skolleborg K, Haugen T, Narum J, et al. Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg. 2006;102(2):418–25.CrossRefPubMed
105.
Grover VK, Mathew PJ, Yaddanapudi S, Sehgal S. A single dose of preoperative gabapentin for pain reduction and requirement of morphine after total mastectomy and axillary dissection: randomized placebo-controlled double-blind trial. J Postgrad Med. 2009;55(4):257–60.CrossRefPubMed
106.
Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101(5):1427–32.CrossRefPubMed
107.
Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg. 2002;95(4):985–91.CrossRefPubMed
108.
Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97(3):560–4.CrossRefPubMed
109.
Bharti N, Bala I, Narayan V, Singh G. Effect of gabapentin pretreatment on propofol consumption, hemodynamic variables, and postoperative pain relief in breast cancer surgery. Acta Anaesthesiol Taiwan. 2013;51(1):10–3.CrossRefPubMed
110.
Mansor SH, Choy CY. Effect of preoperative oral pregabalin on postoperative pain after mastectomy. Middle East J Anesthesiol. 2015;23(1):63–8.PubMed
111.
Kim SY, Song JW, Park B, Park S, An YJ, Shim YH. Pregabalin reduces post-operative pain after mastectomy: a double-blind, randomized, placebo-controlled study. Acta Anaesthesiol Scand. 2011;55(3):290–6.CrossRefPubMed
112.
Freedman BM, O’Hara E. Pregabalin has opioid-sparing effects following augmentation mammaplasty. Aesthetic Surg J. 2008;28(4):421–4.CrossRef
113.
Mir A, Mohebbi N, Omranipour R, Sedaghat M, Lashkari M, Masoomzadeh M. Study of pregabalin effect on postsurgical pain in breast cancer patients: a double-blind randomized clinical trial using placebo. Breast J. 2020;26(11):2286–8.CrossRefPubMed
114.
Hetta DF, Mohamed MA, Mohammad MF. Analgesic efficacy of pregabalin in acute postmastectomy pain: placebo controlled dose ranging study. J Clin Anesth. 2016;34:303–9.CrossRefPubMed
115.
Doha NM, Rady A, Azab SR. Preoperative use of gabapentin decreases the anesthetic and analgesic requirements in patients undergoing radical mastectomy. Egyptian Journal of Anaesthesia. 2010;26(4):287–91.CrossRef
116.
Azemati S, Dokouhaki AG, Talei A, Khademi S, Moin-Vaziri N. Evaluation of the effect of a preoperative single dose of gabapentin on emergence agitation in patients undergoing breast cancer surgery. Middle East Journal of Cancer. 2013;4(4):145–51.
117.
Reyad RM, Omran AF, Abbas DN, Kamel MA, Shaker EH, Tharwat J, Reyad EM, Hashem T. The possible preventive role of pregabalin in postmastectomy pain syndrome: a double-blinded randomized controlled trial. J Pain Symptom Manag. 2019;57(1):1–9.CrossRef
118.
Hetta DF, Elgalaly NA, Hetta HF, Fattah Mohammad MA. Preoperative duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: a dose-ranging randomized controlled trial. J Clin Anesth. 2020;67:110007.
119.
Jacobs A, Lemoine A, Joshi GP, Van de Velde M, Bonnet F. PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2020;75(5):664–73.CrossRefPubMedPubMedCentral
120.
Zhao-Fleming H, Hand A, Zhang K, Polak R, Northcut A, Jacob D, Dissanaike S, Rumbaugh KP. Effect of non-steroidal anti-inflammatory drugs on post-surgical complications against the backdrop of the opioid crisis. Burns Trauma. 2018;6:25.CrossRefPubMedPubMedCentral
121.
Sheth KR, Bernthal NM, Ho HS, Bergese SD, Apfel CC, Stoicea N, Jahr JS. Perioperative bleeding and non-steroidal anti-inflammatory drugs: An evidence-based literature review, and current clinical appraisal. Medicine. 2020;99(31):e20042.
Metadaten
Titel
Perioperative Breast Analgesia: a Systematic Review of the Evidence for Perioperative Analgesic Medications
verfasst von
Robert B. Maniker
James Damiano
Ryan M. J. Ivie
Martin Pavelic
Glenn E. Woodworth
Publikationsdatum
23.02.2022
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 4/2022
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-022-01031-z

Weitere Artikel der Ausgabe 4/2022

Current Pain and Headache Reports 4/2022 Zur Ausgabe

Episodic Migraine (S Nahas, Section Editor)

Integrative, Interventional, and Non-invasive Approaches for the Treatment for Migraine During Pregnancy

Regenerative Pain Medicine/Interventional Pain Medicine (E Cornett Bradley, Section Editor)

Occipital Nerve Stimulation: An Alternative Treatment of Chronic Migraine

Hot Topics in Pain and Headache (N Rosen, Section Editor)

Managing Headache Disorders Associated with Tuberous Sclerosis and Neurofibromatosis

Episodic Migraine (S Nahas, Section Editor)

Episodic Migraine and Older Adults

Chronic Daily Headache (SJ Wang and S Chen, Section Editors)

Resting State Electrophysiological Cortical Activity: A Brain Signature Candidate for Patients with Migraine

Neu im Fachgebiet AINS

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise